Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSL2500112	U3-1402	patritumab deruxtecan	Injection	Biological Products(1)	Import Drug Application	2025-06-24	First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd	view
JXSL2200049	U3-1402	patritumab deruxtecan	Injection	Biological Products(1)	Import Drug Application	2022-04-20	First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd	view
JXSL2101021	U3-1402	patritumab deruxtecan	Injection	Biological Products(1)	Import Drug Application	2021-05-08	First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd	view